The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle‐associated immune complexes
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Immunoglobulins, antigens and complement can assemble to form immune complexes (IC). ICs can be detrimental as they propagate inflammation in autoimmune diseases. Like ICs, submicron extracellular vesicles termed microparticles (MP) are present in the synovial fluid from patients affected with autoimmune arthritis. We examined MPs in rheumatoid arthritis (RA) using high sensitivity flow cytometry and electron microscopy. We find that the MPs in RA synovial fluid are highly heterogeneous in size. The observed larger MPs were in fact MP‐containing ICs (mpICs) and account for the majority of the detectable ICs. These mpICs frequently express the integrin CD41, consistent with platelet origin. Despite expression of the Fc receptor FcγRIIa by platelet‐derived MPs, we find that the mpICs form independently of this receptor. Rather, mpICs display autoantigens vimentin and fibrinogen, and recognition of these targets by anti‐citrullinated peptide antibodies contributes to the production of mpICs. Functionally, platelet mpICs are highly pro‐inflammatory, eliciting leukotriene production by neutrophils. Taken together, our data suggest a unique role for platelet MPs as autoantigen‐expressing elements capable of perpetuating formation of inflammatory ICs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Visualization of the mpICs in RA SF Cryo-TEM detection of immunoglobulins and phosphatidylserine exposing MPs using, respectively protein A-conjugated gold nanoparticles (10 nm) and Annexin-V-conjugated gold nanoparticles (4 nm). A,B. Representative observations obtained using RA SF in which MPs [white boxes labelled MP (MP 1 and MP 2 (A) and MP (B)] were colocalized with ∼2 µm diameter mpICs. White arrows indicate the edge of the IC where MPs were detected. Black arrows indicate the carbon matrix of the perforated support film used for TEM. Insets (bottom panels) include individual MPs. Immunoglobulins detected using protein A conjugated nanospheres (10 nm) are indicated with white arrowheads and MPs detected using Annexin-V conjugated nanospheres (4 nm) are indicated by black arrowheads. Note that some MPs were Annexin-V negative.C. Relatively smaller mpICs were also visualized. White and black arrowheads indicate immunoglobulins and phosphatidylserine, respectively. Scale bars are presented under each panel.](https://figures.cochat.ai/paper-figures/af51c7bd10bc4ec891c9d1eac707a31f/the-exposure-of-autoantigens-by-microparticles-underlies-the-formation-of-potent-figure-2.jpg)




![Figure 7 Platelet mpICs promote leukotriene production by neutrophils Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of RA SF mpICs [n = 3 distinct patients ***p < 0.0001 patients 1 and 2; **p = 0.0011 patient 3 (unpaired t-test, relative to PBS control)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.Platelet mpICs form promptly upon co-incubation of platelet MPs with anti-fibrinogen in vitro. Representative FSC-PMT and SSC dot plot of mpICs. The presence of mpICs formed in vitro was demonstrated using a combination of FITC-conjugated Annexin-V and Alexa 647-conjugated secondary antibody. The four-quadrant gates were positioned according to the isotypic controls. The MPs (Annexin-V+-IgG−) presented in blue show dimensions ranging mostly from 100 to 500 nm (lower inset) while the mpICs (Annexin-V+-IgG+) presented in purple display dimensions ranging from 800 to 3000 nm (upper inset). The relative dimensions are presented according to size-defined microsphere calibrations.Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of in vitro mpICs, anti-fibrinogen and platelet MPs. The stimulatory potency of mpICs compared to the others conditions was statistically significant [n = 3 ***p ≤ 0.0001 (unpaired t-test)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.](https://figures.cochat.ai/paper-figures/b94d7eb7fb544300bab788352d2a97d8/the-exposure-of-autoantigens-by-microparticles-underlies-the-formation-of-potent-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The plasma of patients with SLE contains elevated levels of extracellular vesicle-containing immune complexes compared with healthy individuals, the presence of which is associated with anti-dsDNA antibodies, pro-inflammatory cytokines and disease activity213–217.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [213]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Extracellular vesicles, also referred to microparticles, can also contain mitochondria and can associate with antibodies, forming large extracellular vesicle-containing immune complexes213.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [213]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184 · cited 1×
“Results were displayed in Java TreeView 1 (Version 1.1.3; Eisen et al, 1998).”
InfluentialIsolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
György, B., Szabó, T. G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., László, V., Pállinger, É., Pap, E., Kittel, Á., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0689-3 · Cited by 2,074
The Nature and Significance of Platelet Products in Human Plasma
Wolf, P. (1967) · British Journal of Haematology · doi:10.1111/j.1365-2141.1967.tb08741.x · Cited by 1,720
Platelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692 · cited 1×
“Platelets are highly potent producers of MPs and there is a growing appreciation of the role of platelets in immunity (Boilard et al, 2012; Semple et al, 2011).”
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F. M., Coblyn, J. S., Weinblatt, M. E., Massarotti, E. M., Remold-O’Donnell, E., Farndale, R. W., Ware, J., et al. (2010) · Science · doi:10.1126/science.1181928 · Cited by 1,085 · cited 9×
“Considering their role in arthritis (Boilard et al, 2010, 2012), we queried whether platelet MPs contribute significantly to mpICs in RA SF.”
InfluentialSelf-citationRuiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 831
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A.-S., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J.-L., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 690 · cited 2×
“ICs are also present in multiple inflammatory autoimmune disorders and are reported to propagate disease (Cross et al, 2001; Ho et al, 2010; Korganow et al, 1999; Kuhn et al, 2006; Monach et al, 2009; Munoz et al, 2010; Ruiz-Irastorza et al, 2010; Stuart & Dixon, 1983; Voulgarelis & Tzioufas, 2010;…”
Autoantigen microarrays for multiplex characterization of autoantibody responses
Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., Fournel, S., Fong, D., Genovese, M. C., De Vegvar, H. E. N., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-295 · Cited by 673 · cited 1×
“Using an autoantigen microarray (Hueber et al, 2005; Robinson et al, 2002), we demonstrate that the IgG from platelet mpICs associate with a broad series of recognized citrullinated autoantigens (Fig 6A).”
Self-citation
Cited by
Items 201–254 of 254
Oneyear longitudinal study on biomarkers of blood–brain barrier permeability in COVID-19 patients
Wallensten, J., Havervall, S., Power, Y., Åsberg, M., Borg, K., Nager, A., Thålin, C., & Mobarrez, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-73321-y · Cited by 6
Michael, B. N. R., Misra, D. P., Kavadichanda, C. G., & Negi, V. S. (2018) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_101_18 · Cited by 8
“Few studies have also reported MP-associated immune complexes [11,12] and complement components on their surface [6,13,14] in RA and systemic lupus erythematosus.”
Kanzler, P., Mahoney, A., Leitner, G. C., Witt, V., & Maurer‐Spurej, E. (2016) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2016.12.016 · Cited by 7
Beyond the Biomarker: Monomeric CRP as a Driver of Multisystem Pathology in Rheumatoid Arthritis
Lazarut‐Nistor, A., & SLEVIN, M. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178227 · Cited by 10
“Notably, a large proportion of these EV-associated immune complexes express CD41, a platelet marker, suggesting that many of these immunogenic EVs originate from platelets [20].”
Investigating and imaging platelets in inflammation
Cleary, S. J., & Conrad, C. (2023) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2023.106373 · Cited by 6
Recent Advancements and Applications of Size Exclusion Chromatography in Modern Analysis
Bhatia, R., Kumari, Y., & Chopra, A. (2023) · Current Analytical Chemistry · doi:10.2174/1573411019666230526144816 · Cited by 8
Reni, B. N., Mariaselvam, C. M., Kavadichanda, C. G., & Negi, V. S. (2023) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14912 · Cited by 8
“5 However only citrulline + MP-ICs were found to be significantly elevated in RA-SF compared with psoriatic arthritis 5 and they were also found to be associated with systemic inflammation in seropositive RA.”
BackgroundExtracellular vesicle autoantibodies
Yan, H., Jiang, P., Dai, C., & Li, M. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103322 · Cited by 6
Soucy, M. N., Hébert, M. P. A., Doiron, J. A., Barnett, D. A., Lamarre, S. G., Hébert-Chatelain, É., & Boudreau, L. H. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf119 · Cited by 6
“28,29 Not only are PMVs found to be associated with immune complexes capable of inducing the inflammatory response, 30 but also our team discovered a previously unreported subtype of PMVs in the synovial fluid of RA patients that retains functional mitochondria, termed mitochondria-containing…”
Self-citationZheng, A., Liu, H., Yin, G., & Xie, Q. (2025) · Immunologic Research · doi:10.1007/s12026-025-09723-5 · Cited by 6
“M-Exos have been implicated in immune complex formation [64, 148], disease diagnosis and prediction [149], and therapeutic interventions [150] in autoimmune diseases.”
Losada, P. X., Serrato, L. M., Zapata, A. M. D., Vanegas-García, A. L., Muñoz, C. H., Rodríguez, D., Diaz, J. C., Pineda, R., Lopez, M. R., & Vásquez, G. M. (2024) · Lupus Science & Medicine · doi:10.1136/lupus-2024-001243 · Cited by 6
“38 Although the magnitude of the ζ potential fluctuates depending on the electrochemical characteristics at the particle-medium interface and can be affected by factors such as surface chemistry, pH and ionic strength of the medium, 28 patient and control samples were processed and analysed under…”
Boilard, É., & Nigrovic, P. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00016-4 · Cited by 5
Self-citationDifferent Contribution of Monocyte- and Platelet-Derived Microvesicles to Endothelial Behavior
Brambilla, M., Talmon, M., Canzano, P., Fresu, L. G., Brunelleschi, S., Tremoli, E., & Camera, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094811 · Cited by 6
“Studies carried out in patients with cardiovascular diseases have shown that MVs derived from platelets (Plt-MVs), which represent 70% to 90% of the circulating large extracellular vesicles, express high levels of membrane phosphatidylserine, P-selectin and tissue factor (TF) [12] and carry the procoagulant phenotype…”
BackgroundPlatelet proteomics applied to the search for novel antiplatelet therapeutic targets
Izquierdo, I., & García, Á. G. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1246188 · Cited by 5
“PMVs are involved in intercellular communication [32] and are also known to be key effectors in important processes like coagulation [33,34] and inflammation [35,36].”
BackgroundBiomaterials and MSCs composites in regenerative medicine
Liu, C., Shao, C., Zhang, L., & Huang, Q. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95346-7.00004-x · Cited by 6
Mustonen, A., Capra, J., Oikari, S., Säïsänen, L., Karttunen, L., Julkunen, P., Lehenkari, P. P., Joukainen, A., Jaroma, A., Paakkonen, T., et al. (2024) · Cartilage · doi:10.1177/19476035241247659 · Cited by 4
“6 However, large EVs detected in RA SF can associate with autoantigens, be citrullinated, and form bioactive inflammatory immune complexes, 7 indicating that their potential effects would be significant enough to be included in studies of EVs.”
InfluentialExosomal Protein Biomarkers in Arthritis: Deciphering the Inflammatory Profiles of RA and OA
Gómez, C. M. B., Plasencia‐Rodríguez, C., Novella-Navarro, M., Martínez‐Feito, A., Balsa, A., Calvo-Aranda, E., & Hernández‐Breijo, B. (2025) · Biomedicines · doi:10.3390/biomedicines13061283 · Cited by 5
“Leukocyte markers showed clear differences among patients with RA or OA and HCs. Monocytes and macrophages are known to be key players in RA pathogenesis, releasing high amounts of proinflammatory cytokines like IL-6 and IL-1b, and this is clearly reflected in our results [25].”
Platelet microparticles in transfusion
Boudreau, L. H., Marcoux, G., & Boilard, É. (2015) · ISBT Science Series · doi:10.1111/voxs.12142 · Cited by 4
Self-citationPlatelets and Bacterial Infections
Rondina, M. T., Garraud, O., & Schwertz, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_71 · Cited by 4
Is It Time to Bring Back Knee Washout?
Ike, R. W., & KALUNIAN, K. C. (2022) · The Journal of Rheumatology · doi:10.3899/jrheum.211132 · Cited by 4
Platelet Functions Beyond Hemostasis
Kapur, R., & Semple, J. W. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_10 · Cited by 5
Deposition of platelet-derived microparticles in podocytes contributes to diabetic nephropathy
Huang, S. J., Zhang, Y., Wang, G. H., Lü, J., Chen, P. P., Zhang, J. X., Li, X. Q., Yuan, B. Y., Liu, X. Q., Jiang, T., et al. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03332-z · Cited by 4
“showed that PMPs amplified the inflammatory response by forming immune complexes and stimulating leukotriene production of neutrophils in rheumatoid arthritis [27].”
BackgroundJayawardena, I., Wilson, K., Plebanski, M., Grøndahl, L., & Corrie, S. R. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c01042 · Cited by 4
Manipulating the Matrix: Role of Extracellular Vesicles
Anto, V. P., Montanari, K. M., Hussey, G. S., & Badylak, S. F. (2024) · Biology of extracellular matrix · doi:10.1007/978-3-031-68811-9_1 · Cited by 3
DNA coronas resist nuclease degradation
Anees, F., Montoya, D. A., Pisetsky, D. S., Khan, T., Kalpattu, A., & Payne, C. K. (2025) · Biophysical Journal · doi:10.1016/j.bpj.2025.05.028 · Cited by 3
“…and microparticles in plasma isolated from SLE patients and synovial fluid from patients with rheumatoid arthritis have also been observed (33,34), but it is possible that the larger diameter is due to the inclusion of mitochondria in the particles or immunoglobulin binding to form immune…”
Platelet immunobiology: platelets as prey and predator
Kapur, R., & Semple, J. W. (2017) · ISBT Science Series · doi:10.1111/voxs.12375 · Cited by 3
Platelet-derived non-coding RNAs as emerging contributors to autoimmune inflammation
El‐Sehrawy, A. A. M. A., Saleh, R. O., Alzahrani, A. A., Asiri, M., Ganesan, S., Kundlas, M., Premkumar, J., Ray, S., Hussein, A., & Alnajar, M. J. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04943-w · Cited by 2
Muñoz‐Grajales, C., Ucciferri, C. C., Johnson, S. R., Touma, Z., Ahmad, Z., Bonilla, D., Hiraki, L. T., BOOKMAN, A. A. M., & Wither, J. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43323 · Cited by 3
“16, 37 However, to our knowledge , this is”
Curry, B. J. (2014) · Cited by 3
Kassassir, H., Siewiera, K., Przygodzki, T., Łabieniec-Watała, M., & Watała, C. W. (2016) · InTech eBooks · doi:10.5772/63473 · Cited by 2
“When activating the platelets preloaded with this reagent, the fluorescence gets encapsulated within microparticles, permitting their closer identification [127].”
Cell-Derived Microparticles/Exosomes in Neuroinflammation
Horstman, L. L., Jy, W., & Ahn, Y. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-51220-4_6 · Cited by 2
Sasaki, G. H. (2021) · OALib · doi:10.4236/oalib.1107393 · Cited by 2
Noor, N. A. M., Marhalim, S. Z., Ariffin, N. A. F. M., Suppıan, R., & Azlan, M. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i6.747 · Cited by 2
Jiang, W., Tang, W. H., & Zhang, Y. (2026) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00610.2025 · Cited by 2
Circulating Microparticle Double-Stranded Deoxyribonucleic Acid in Systemic Lupus Erythematosus
Tay, S. H., Lateef, A., Lim, Y. C., Ng, I. J., Koh, D. R., & Lim, L. H. K. (2016) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v45n8p373 · Cited by 1
Kapur, R., & Semple, J. W. (2018) · Springer eBooks · doi:10.1007/978-3-319-68038-5_17 · Cited by 1
Large Granular Lymphocyte Leukemia
Dziewulska, K. H., Moosic, K. B., Cheon, H., Olson, K. C., Feith, D. J., & Loughran, T. P. (2021) · Wiley eBooks · doi:10.1002/9781119671336.ch14 · Cited by 1
Cellular Stress Induced by Plasma-Derived Factor VIII Products
Brodde, M. F., Müller, A., & Kehrel, B. E. (2014) · Transfusion Medicine and Hemotherapy · doi:10.1159/000357992
The Role of Microparticles as Biomarkers in the Development of Therapy for Autoimmune Disease
Pisetsky, D. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-42252-7_3
Puga, M. L. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-06122021-145808
Alipour, R., Sereshki, N., Rafiee, M., Mofid, M. R., Alsahebfosoul, F., & Pourazar, A. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152193
Histone Deacetylase 6 at Crossroads of Invection and Innate Immunity
Moreno-Gonzalo, O. (2018) · doi:10.4321/repisalud.7741
Nanovesicles for targeting autoimmune diseases
Andleeb, R., Ijaz, M. U., Ashraf, A., Rafi, R., Yeni, D. K., Naz, S., Ali, T., & Sajid, M. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00013-4 · Cited by 1
Extracellular Vesicles in Synovial Fluid: Their Role in Joint Homeostasis and Pathophysiology
Ragni, E., & de Girolamo, L. (2024) · Biology of extracellular matrix · doi:10.1007/978-3-031-68811-9_6 · Cited by 1
Rincón-Arévalo, H., Burbano, C., Atehortúa, L., Rojas, M., García, A. L. V., Vásquez, G., & Castaño, D. (2022) · Figshare · doi:10.6084/m9.figshare.20329845
Exosomes as cellular couriers: the mechanisms of intercellular messaging
Reddy, M. M. S., Srivastava, A. K., & Prabhakaran, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36390-0.00009-9
Plaquettes sanguines et entretien de l’inflammation post-infectieuse
Damien, P. (2013) · theses.fr (ABES) · doi:10.70675/61bbcbffz7bf4z44e3z8a02z38c7c17b1c32 · Cited by 1
Cointe, S. (2015) · theses.fr (ABES) · doi:10.70675/1e7a39c1z1f87z4da1z8567ze0edb3712efa
Rôle inflammatoire des plaquettes sanguines lors du sepsis
Chabert, A. (2017) · theses.fr (ABES) · doi:10.70675/bf41a02ez6e11z4d57zb862z4383855ebed9 · Cited by 2
López, S. C., Lopera, T. J., Restrepo, V., Carbal, L. F., Ramírez-Mejía, J. M., Hernández, A. H., Gil, D., Díaz, J.-C., Manrique-Moreno, M., Barazzuol, L., et al. (2026) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2026.100387
“These EV-associated molecules can be recognized by the immune system and promote proinflammatory responses, highlighting EVs as active participants in disease pathogenesis [14 – 16].”
Semple, J. W., Rebetz, J., Provan, D., & Kapur, R. (2026) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2026.09.015
Metadata
- Authors
- Cloutier, N., Tan, S., Boudreau, L. H., Cramb, C., Subbaiah, R., Lahey, L., Albert, A., Shnayder, R., Gobezie, R., Nigrovic, P. A., Farndale, R. W., Robinson, W. H., Brisson, A., Lee, D. M., & Boilard, E.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- Chimie et Biologie des Membranes et des Nanoobjects (FR)
- Stanford Medicine (US)
- Case Western Reserve University (US)
- Brigham and Women's Hospital (US)
- University Hospitals of Cleveland (US)
- University of Cambridge (GB)
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2012-12-11
- Volume
- 5
- Issue
- 2
- Pages
- 235-249
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3569640
- OpenAlex
- W2123391301
- Cited by
- 254
- References
- 72
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 14 · 2023: 18 · 2022: 27 · 2021: 21 · 2020: 21 · 2019: 26 · 2018: 26 · 2017: 23 · 2016: 27 · 2015: 22 · 2014: 6 · 2013: 7
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Arthritis Society
- British Heart Foundation (RG/09/003/27122)
- National Institutes of Health (5p01ai065858-05, AI065858)
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (P01 AI-065858)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR065538)
- Canadian Arthritis Network
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- microparticles, immune complexes, rheumatoid arthritis, platelets, autoantigens, vimentin, fibrinogen, anti-citrullinated protein antibodies, synovial fluid, CD41, FcγRIIa, neutrophil activation, leukotriene biosynthesis, inflammation, autoimmune arthritis, extracellular vesicles
- MeSH terms
- Antigen-Antibody Complex, Arthritis, Rheumatoid, Autoantigens, Humans, Particle Size, Synovial Fluid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.